Leap Therapeutics Inc. (LPTX) NASDAQ
$2.77 0.02 (0.73%)
Market Cap: $105.23M
As of 05/15/24 02:45 PM EDT. Market open.
Leap Therapeutics Inc. (LPTX)
NASDAQ
$2.77
0.02 (0.73%)
Market Cap: $105.23M
As of 05/15/24 02:45 PM EDT. Market open.
Add to Portfolio
leap therapeutics (nasdaq: lptx) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. for more information about leap therapeutics, visit http://www.leaptx.com or our public filings with the sec that are available via edgar at http://www.sec.gov or via ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
34
URL
Address
47 Thorndike St Ste B1-1, Massachusetts, Cambridge, 02141-1799.
PRICE CHART FOR LEAP THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.76
Previous Close
$2.75
Days Range
$2.72 - $2.98
52 week range
$1.24 - $10.20
Volume
229,358
Avg. Volume (30 days)
192,459
Market Cap
$105.23M
Dividend Yield
-
P/E
-
Shares Outstanding
38,264,464
Open
$2.76
Previous Close
$2.75
Days Range
$2.72 - $2.98
52 week range
$1.24 - $10.20
Volume
229,358
Avg. Volume (30 days)
192,459
Market Cap
$105.23M
Dividend Yield
-
P/E
-
Shares Outstanding
38,264,464
FINANCIAL STATEMENTS FOR LEAP THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR LEAP THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| BeiGene, Ltd. | 10% Owner | Sep 24, 2021 | Buy | $2.85 | 2,543,800 | 7,249,830 | 7,348,437 | Sep 28, 2021, 05:48 PM |
| PERCEPTIVE ADVISORS LLC | 10% Owner | Jun 22, 2020 | Buy | $2.00 | 1,750,000 | 3,500,000 | 8,476,496 | Jun 24, 2020, 07:00 PM |
| ONSI DOUGLAS E | CFO, GC, Treasurer & Secretary | Feb 05, 2019 | Buy | $1.75 | 571,428 | 999,999 | 4,114,804 | Feb 05, 2019, 04:22 PM |
| LAWLOR AUGUSTINE | Chief Operating Officer | Feb 05, 2019 | Buy | $1.75 | 571,428 | 999,999 | 4,114,804 | Feb 05, 2019, 04:21 PM |
| Mirabelli Christopher | CEO, President, Chairman | Feb 05, 2019 | Buy | $1.75 | 571,428 | 999,999 | 4,114,804 | Feb 05, 2019, 04:20 PM |
| HealthCare Ventures IX, L.P. | 10% Owner | Feb 05, 2019 | Buy | $1.75 | 571,428 | 999,999 | 4,144,804 | Feb 05, 2019, 04:19 PM |
| ONSI DOUGLAS E | CFO, GC, Treasurer & Secretary | Nov 14, 2017 | Buy | $6.09 | 1,057,769 | 6,436,524 | 3,573,376 | Nov 16, 2017, 01:45 PM |
| Mirabelli Christopher | CEO, President, COB | Nov 14, 2017 | Buy | $6.09 | 1,057,769 | 6,436,524 | 3,573,376 | Nov 16, 2017, 01:45 PM |
| HealthCare Ventures IX, L.P. | 10% Owner | Nov 14, 2017 | Buy | $6.09 | 1,057,769 | 6,436,524 | 3,573,376 | Nov 16, 2017, 01:45 PM |
| LAWLOR AUGUSTINE | Chief Operating Officer | Nov 14, 2017 | Buy | $6.09 | 1,057,769 | 6,436,524 | 3,573,376 | Nov 16, 2017, 01:45 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| BeiGene, Ltd. | 10% Owner | 09/24/2021 | 7,249,830 |
| PERCEPTIVE ADVISORS LLC | 10% Owner | 06/22/2020 | 3,500,000 |
| ONSI DOUGLAS E | CFO, GC, Treasurer & Secretary | 02/05/2019 | 999,999 |
| LAWLOR AUGUSTINE | Chief Operating Officer | 02/05/2019 | 999,999 |
| Mirabelli Christopher | CEO, President, Chairman | 02/05/2019 | 999,999 |
| HealthCare Ventures IX, L.P. | 10% Owner | 02/05/2019 | 999,999 |
| ONSI DOUGLAS E | CFO, GC, Treasurer & Secretary | 11/14/2017 | 6,436,524 |
| Mirabelli Christopher | CEO, President, COB | 11/14/2017 | 6,436,524 |
| HealthCare Ventures IX, L.P. | 10% Owner | 11/14/2017 | 6,436,524 |
| LAWLOR AUGUSTINE | Chief Operating Officer | 11/14/2017 | 6,436,524 |
Load More Insider Transactions
FUNDS WITH A POSITION IN LEAP THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 1,172,175 | 0.06% | No change | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 480,000 | 0.00241% | -49.09% | Other |
| BALYASNY ASSET MANAGEMENT L.P. | 670,543 | 0.00312% | New | Event Driven |
| GEODE CAPITAL MANAGEMENT, LLC | 202,572 | 0.00005% | -0.68% | Other |
| OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) | 107,412 | 0.02% | -25.19% | Value |
| RENAISSANCE TECHNOLOGIES LLC | 114,470 | 0.00048% | 692.18% | Other |
| BLACKROCK INC. | 29,298 | 0% | -69.21% | Other |
CHANGE IN SHARES OUTSTANDING FOR LEAP THERAPEUTICS INC
STOCK BUYBACKS FOR LEAP THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.10%
2Q
BUYBACK ANNOUNCEMENT(S) FOR LEAP THERAPEUTICS INC
LOADING...